TELA Bio (TELA) Total Liabilities (2018 - 2026)

TELA Bio's Total Liabilities history runs 9 years deep, the most recent figure standing at $75.1 million for Q1 2026.

• On a quarterly basis, Total Liabilities rose 27.0% year-over-year to $75.1 million in Q1 2026; TTM through Mar 2026 was $75.1 million, a 27.0% increase from a year earlier, with the FY2025 full-year figure at $75.1 million, up 29.24% from the prior year.
• Total Liabilities steadied at $75.1 million in Q1 2026 per TELA's latest filing, from $75.1 million in the prior quarter.
• Across five years, Total Liabilities topped out at $75.1 million in Q4 2025 and bottomed at $45.3 million in Q1 2022.
• The 5-year median for Total Liabilities is $57.5 million (2024), against an average of $58.5 million.
• Across the five-year window, Total Liabilities jumped 36.96% in 2022 and declined 1.78% in 2024, its largest moves.
• Year by year, Total Liabilities stood at $53.6 million in 2022, then rose by 10.49% to $59.2 million in 2023, then slipped by 1.78% to $58.1 million in 2024, then rose by 29.24% to $75.1 million in 2025, then fell by 0.02% to $75.1 million in 2026.
• Per Business Quant, the three latest TELA Total Liabilities figures stand at $75.1 million (Q1 2026), $75.1 million (Q4 2025), and $60.0 million (Q3 2025).